3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
2
Gastrointestinal
1
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
3
Rectal Neoplasms
3
Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Prostatic Neoplasms
2
Pancreatic cancer, adult
2
Lung Neoplasms
2
Recurrence
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Glioblastoma
1
Fibrosis
1
Fatigue
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Fluorouracil
98
Oxaliplatin
94
Leucovorin
86
Irinotecan
70
Gemcitabine
66
Bevacizumab
62
Capecitabine
60
Cetuximab
42
pembrolizumab
38
Cisplatin
31
Nivolumab
25
Drug Therapy
25
130-nm albumin-bound paclitaxel
22
Specimen Handling
20
Folfox protocol
20
Panitumumab
19
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Albumin-Bound Paclitaxel
17
Biopsy
16
IFL protocol
15
Floxuridine
15
Docetaxel
15
Cyclophosphamide
15
Sorafenib
14
regorafenib
12
Erlotinib Hydrochloride
12
aflibercept
11
Radiofrequency Ablation
11
Carboplatin
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Hematologic Tests
×
Gastrointestinal
×
Clear all
NCT05648240
2026-02-10
EARDIS
Centre Hospitalier Universitaire de NÄ«mes
Completed
120 enrolled